-+ 0.00%
-+ 0.00%
-+ 0.00%

DR. REDDY’S ANNOUNCES USFDA ACCEPTANCE TO REVIEW ITS BIOLOGICS LICENSE APPLICATION (BLA) FOR PROPOSED INTERCHANGEABLE BIOSIMILAR, ABATACEPT

Reuters·02/20/2026 15:57:00

Please log in to view news